The glutaminase (GLS1) inhibitor IACS-6274, discovered and developed by The University of Texas MD Anderson Cancer Center’s Therapeutics Discovery division, appears to be well-tolerated with successful target inhibition and early signs of anti-tumor activity in a biomarker-driven Phase I trial. Interim results of the study will be presented at the 2021 American Society for Clinical Oncology (ASCO) Annual Meeting on June 4.
Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. However, these micronutrients are not produced in our
Macronutrients hog the spotlight. Everyone is talking about eating the right amount of proteins, fats, and carbohydrates for fitness goals, but there’s another type of
Commercial gyms are closed for at least the next couple of months due to the coronavirus outbreak. As a result, people are left scrambling to
Low testosterone is no joke. Did you know that testosterone levels in men have been on a steady decline since the 1980s? One study found
